The Pharma Letter Podcast by

July 2021.

Israel-based Belong.Life is the creator of the world’s largest social network for cancer patients, and has ambitions to provide a range of networks across therapy areas.

The platform may be of interest for drug developers and other industry participants looking for opportunities to conduct market research or marketing efforts, or to boost clinical trial enrolment.

In this episode, The Pharma Letter discusses the potential for the platform with its chief executive, Eliran Malki, and medical director, Daniel Vorobiof.

Listen Now >

More Articles

Breast Cancer and Diet: Expert Tips

Following a healthy diet – including nutrient-dense, plant-based foods and lean animal proteins – may…

Expect These Healthcare Trends in 2024

Artificial intelligence will push into new territories to advance revenue management, health equity, and workforce…

Is it the Future of Medicine?

Interview with Irad Deutsch, Co-founder and CTO of Belong, a company that developed Dave –…
Skip to content